Archives of Neurology · 2001 · 128 citations · 8 references
Life SciencesNeurologyNeuroscienceClinical NeuroscienceNeuroimmunologyNeuropathologyCerebrospinal Fluid BiomarkersDemyelinating DiseasesDemyelinating DisordersMultiple SclerosisNeurologic PrognosticationNeurological AssessmentCerebrospinal Fluid Oligoclonal BandsPrognostic Interpretation
The natural course of disease in multiple sclerosis varies. Multiple sclerosis that is clinically apparent but causes minimal disability over time has been labeled benign multiple sclerosis. The ability to predict the subsequent clinical course of multiple sclerosis on the basis of clinical and other supportive data at presentation would be invaluable. In this article we report our findings based on a retrospective analysis of 1800 patients diagnosed as having multiple sclerosis, of which 44 patients met our inclusion criteria. There was a suggestion that a low or absent number of oligoclonal bands in the cerebrospinal fluid at the time of diagnosis predicts a better prognosis. However, quantification of oligoclonal bands in cerebrospinal fluid remains an insensitive prognostic indicator and must not be used to influence decisions regarding therapeutic options.
8
Defining the clinical course of multiple sclerosis
Fred Lublin, Stephen C. Reingold · Neurology · 1996 · 3.7K citations
Studies on the natural history of multiple sclerosis—8
John F. Kurtzke, Gilbert W. Beebe, Benedict Nagler et al. · Journal of Chronic Diseases · 1977 · 166 citations
A study of oligoclonal band negative multiple sclerosis.
Adam Zeman, Desmond P. Kidd, Brendan McLean et al. · Journal of Neurology Neurosurgery & Psychiatry · 1996 · 161 citations · Full text